AAVDiff: Experimental Validation of Enhanced Viability and Diversity in Recombinant Adeno-Associated Virus (AAV) Capsids through Diffusion Generation

• URL: http://arxiv.org/abs/2404.10573v2
• Date: Wed, 17 Apr 2024 12:08:46 GMT
• Title: AAVDiff: Experimental Validation of Enhanced Viability and Diversity in Recombinant Adeno-Associated Virus (AAV) Capsids through Diffusion Generation
• Authors: Lijun Liu, Jiali Yang, Jianfei Song, Xinglin Yang, Lele Niu, Zeqi Cai, Hui Shi, Tingjun Hou, Chang-yu Hsieh, Weiran Shen, Yafeng Deng,
• Abstract summary: In this study, we propose an end-to-end diffusion model to generate capsid sequences with enhanced viability. We generated 38,000 diverse AAV2 viral protein (VP) sequences, and evaluated 8,000 for viral selection. In the absence of AAV9 capsid data, apart from one wild-type sequence, we used the same model to directly generate a number of viable sequences with up to 9 mutations.
• Score: 7.8254313735368255
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Recombinant adeno-associated virus (rAAV) vectors have revolutionized gene therapy, but their broad tropism and suboptimal transduction efficiency limit their clinical applications. To overcome these limitations, researchers have focused on designing and screening capsid libraries to identify improved vectors. However, the large sequence space and limited resources present challenges in identifying viable capsid variants. In this study, we propose an end-to-end diffusion model to generate capsid sequences with enhanced viability. Using publicly available AAV2 data, we generated 38,000 diverse AAV2 viral protein (VP) sequences, and evaluated 8,000 for viral selection. The results attested the superiority of our model compared to traditional methods. Additionally, in the absence of AAV9 capsid data, apart from one wild-type sequence, we used the same model to directly generate a number of viable sequences with up to 9 mutations. we transferred the remaining 30,000 samples to the AAV9 domain. Furthermore, we conducted mutagenesis on AAV9 VP hypervariable regions VI and V, contributing to the continuous improvement of the AAV9 VP sequence. This research represents a significant advancement in the design and functional validation of rAAV vectors, offering innovative solutions to enhance specificity and transduction efficiency in gene therapy applications.

Related papers

• AAVGen: Precision Engineering of Adeno-associated Viral Capsids for Renal Selective Targeting [0.0]
  AAVGen is a generative artificial intelligence framework for de novo design of AAV capsids with enhanced multi-trait profiles.<n>AAVGen integrates a protein language model (PLM) with supervised fine-tuning (SFT) and a reinforcement learning technique termed Group Sequence Policy Optimization (GSPO)<n>Our results demonstrate that AAVGen produces a diverse library of novel VP1 protein sequences.
  arXiv  Detail & Related papers  (2026-02-21T17:46:34Z)
• Neuromorphic Spiking Neural Network Based Classification of COVID-19 Spike Sequences [4.497217246897902]
  We propose a neural network-based (NN) mechanism to perform an efficient analysis of the SARS-CoV-2 data. In this paper, we introduce a pipeline that first converts the spike protein sequences into a fixed-length numerical representation and then uses Neuromorphic Spiking Neural Network to classify those sequences.
  arXiv  Detail & Related papers  (2024-12-19T10:26:31Z)
• Improved Anomaly Detection through Conditional Latent Space VAE Ensembles [49.1574468325115]
  Conditional Latent space Variational Autoencoder (CL-VAE) improved pre-processing for anomaly detection on data with known inlier classes and unknown outlier classes. Model shows increased accuracy in anomaly detection, achieving an AUC of 97.4% on the MNIST dataset. In addition, the CL-VAE shows increased benefits from ensembling, a more interpretable latent space, and an increased ability to learn patterns in complex data with limited model sizes.
  arXiv  Detail & Related papers  (2024-10-16T07:48:53Z)
• Dense Feature Memory Augmented Transformers for COVID-19 Vaccination Search Classification [60.49594822215981]
  This paper presents a classification model for detecting COVID-19 vaccination related search queries. We propose a novel approach of considering dense features as memory tokens that the model can attend to. We show that this new modeling approach enables a significant improvement to the Vaccine Search Insights (VSI) task.
  arXiv  Detail & Related papers  (2022-12-16T13:57:41Z)
• Benchmarking Machine Learning Robustness in Covid-19 Genome Sequence Classification [109.81283748940696]
  We introduce several ways to perturb SARS-CoV-2 genome sequences to mimic the error profiles of common sequencing platforms such as Illumina and PacBio. We show that some simulation-based approaches are more robust (and accurate) than others for specific embedding methods to certain adversarial attacks to the input sequences.
  arXiv  Detail & Related papers  (2022-07-18T19:16:56Z)
• COVID-Net US-X: Enhanced Deep Neural Network for Detection of COVID-19 Patient Cases from Convex Ultrasound Imaging Through Extended Linear-Convex Ultrasound Augmentation Learning [75.74756992992147]
  The global population continues to face significant negative impact by the on-going COVID-19 pandemic. There has been an increasing usage of point-of-care ultrasound (POCUS) imaging as a low-cost effective imaging modality of choice. A major challenge to building deep neural networks for COVID-19 screening using POCUS is the types of probes used.
  arXiv  Detail & Related papers  (2022-04-29T02:13:39Z)
• Using Deep Learning Sequence Models to Identify SARS-CoV-2 Divergence [1.9573380763700707]
  SARS-CoV-2 is an upper respiratory system RNA virus that has caused over 3 million deaths and infecting over 150 million worldwide as of May 2021. We propose a neural network model that leverages recurrent and convolutional units to take in amino acid sequences of spike proteins and classify corresponding clades.
  arXiv  Detail & Related papers  (2021-11-12T07:52:11Z)
• PhyloTransformer: A Discriminative Model for Mutation Prediction Based on a Multi-head Self-attention Mechanism [10.468453827172477]
  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an ongoing pandemic infecting 219 million people as of 10/19/21, with a 3.6% mortality rate. Here we developed PhyloTransformer, a Transformer-based discriminative model that engages a multi-head self-attention mechanism to model genetic mutations that may lead to viral reproductive advantage.
  arXiv  Detail & Related papers  (2021-11-03T01:30:57Z)
• Robust Representation and Efficient Feature Selection Allows for Effective Clustering of SARS-CoV-2 Variants [0.0]
  The SARS-CoV-2 virus contains different variants, each of them having different mutations. Much of the variation in the SARS-CoV-2 genome happens disproportionately in the spike region of the genome sequence. We propose an approach to cluster spike protein sequences in order to study the behavior of different known variants.
  arXiv  Detail & Related papers  (2021-10-18T21:18:52Z)
• Effective and scalable clustering of SARS-CoV-2 sequences [0.41998444721319206]
  SARS-CoV-2 continues to mutate as it spreads, according to an evolutionary process. The number of currently available sequences of SARS-CoV-2 in public databases such as GISAID is already several million. We propose an approach based on clustering sequences to identify the current major SARS-CoV-2 variants.
  arXiv  Detail & Related papers  (2021-08-18T13:32:43Z)
• A k-mer Based Approach for SARS-CoV-2 Variant Identification [55.78588835407174]
  We show that preserving the order of the amino acids helps the underlying classifiers to achieve better performance. We also show the importance of the different amino acids which play a key role in identifying variants and how they coincide with those reported by the USA's Centers for Disease Control and Prevention (CDC)
  arXiv  Detail & Related papers  (2021-08-07T15:08:15Z)
• CovidDeep: SARS-CoV-2/COVID-19 Test Based on Wearable Medical Sensors and Efficient Neural Networks [51.589769497681175]
  The novel coronavirus (SARS-CoV-2) has led to a pandemic. The current testing regime based on Reverse Transcription-Polymerase Chain Reaction for SARS-CoV-2 has been unable to keep up with testing demands. We propose a framework called CovidDeep that combines efficient DNNs with commercially available WMSs for pervasive testing of the virus.
  arXiv  Detail & Related papers  (2020-07-20T21:47:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.